Premium
Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder
Author(s) -
Palea S,
Toson G,
Pietra C,
Trist D G.,
Artibani W,
Romano O,
Corsi M
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0701903
Subject(s) - agonist , endocrinology , medicine , thromboxane a2 , chemistry , antagonist , prostanoid , thromboxane , stimulation , receptor antagonist , receptor , contraction (grammar) , platelet
Cumulative concentration‐response curves (CRC) to prostaglandin E 1 (PGE 1 ), PGE 2 , PGD 2 and PGF 2α (0.01–30 μ M ) and to the thromboxane A 2 (TXA 2 ) receptor agonist U‐46619 (0.01–30 μ M ) were constructed in human isolated detrusor muscle strips both in basal conditions and during electrical field stimulation. All the agonists tested contracted the detrusor muscle. The rank order of agonist potency was: PGF 2α >U‐46619>PGE 2 whereas weak contractile responses were obtained with PGD 2 and PGE 1 . Any of the agonists tested was able to induce a clear plateau of response even at 30 μ M . The selective TXA 2 antagonist, GR 32191B (vapiprost), antagonized U‐46619‐induced contractions with an apparent pK B value of 8.27±0.12 ( n =4 for each antagonist concentration). GR 32191B (0.3 μ M ) did not antagonize the contractile responses to PGF 2α and it was a non‐surmountable antagonist of PGE 2 (apparent pK B of 7.09±0.04; n =5). The EP receptor antagonist AH 6809 at 10 μ M shifted to the right the CRC to U‐46619 (apparent pK B value of 5.88±0.04; n =4). Electrical field stimulation (20 Hz, 70 V, pulse width 0.1 ms, trains of 5 s every 60 s) elicited contractions fully sensitive to TTX (0.3 μ M ) and atropine (1 μ M ). U‐46619 (0.01–3 μ M ) potentiated the twitch contraction in a dose‐dependent manner and this effect was competitively antagonized by GR 32191B with an estimated pK B of 8.54±0.14 ( n =4 for each antagonist concentration). PGF 2α in the range 0.01–10 μ M ( n =7), but not PGE 2 and PGE 1 ( n =3 for each), also potentiated the twitch contraction of detrusor muscle strips (23.5±0.3% of KCl 100 m M ‐induced contraction) but this potentiation was unaffected by 0.3 μ M GR 32191B ( n =5). Cumulative additions of U‐46619 (0.01–30 μ M ) were without effect on contractions induced by direct smooth muscle excitation (20 Hz, 40 V, 6 ms pulse width, trains of 2 s every 60 s, in the presence of TTX 1 μ M ; n =3). Moreover, pretreatment of the tissue with 0.3 μ M U‐46619 did not potentiate the smooth muscle response to 7 μ M bethanecol ( n =2). We concluded that TXA 2 can induce direct contraction of human isolated urinary bladder through the classical TXA 2 receptor. Prostanoid receptors, fully activated by PGE 2 and PGF 2α are also present. All these receptors are probably located post‐junctionally. The rank order of agonist potency and the fact that GR32191B, but not AH6809, antagonized responses to PGE 2 seem to indicate the presence of a new EP receptor subtype. Moreover, we suggest the presence of prejuctional TXA 2 and FP receptors, potentiating acetylcholine release from cholinergic nerve terminals.